The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Protein tyrosine phosphatases as potential therapeutic targets
Open accessAbstract
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human diseases, such as cancers, diabetes, autoimmune disorders, and neurological diseases. Indeed, protein tyrosine phosphorylation-mediated signaling events offer ample therapeutic targets, and drug discovery efforts to date have brought over two dozen kinase inhibitors to the clinic. Accordingly, protein tyrosine phosphatases (PTPs) are considered next-generation drug targets. For instance, PTP1B is a well-known targets of type 2 diabetes and obesity, and recent studies indicate that it is also a promising target for breast cancer. SHP2 is a bona-fide oncoprotein, mutations of which cause juvenile myelomonocytic leukemia, acute myeloid leukemia, and solid tumors. In addition, LYP is strongly associated with type 1 diabetes and many other autoimmune diseases. This review summarizes recent findings on several highly recognized PTP family drug targets, including PTP1B, Src homology phosphotyrosyl phosphatase 2(SHP2), lymphoid-specific tyrosine phosphatase (LYP), CD45, Fas associated phosphatase-1 (FAP-1), striatal enriched tyrosine phosphatases (STEP), mitogen-activated protein kinase/dual-specificity phosphatase 1 (MKP-1), phosphatases of regenerating liver-1 (PRL), low molecular weight PTPs (LMWPTP), and CDC25. Given that there are over 100 family members, we hope this review will serve as a road map for innovative drug discovery targeting PTPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine · doi:10.1038/89044 · Cited by 2,644
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Begovich, A. B., Carlton, V. E. H., Honigberg, L. A., Schrodi, S. J., Chokkalingam, A. P., Alexander, H. C., Ardlie, K. G., Huang, Q., Smith, A. M., Spoerke, J. M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422827 · Cited by 1,502
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G. F., Lucarelli, P., Pellecchia, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1323 · Cited by 1,424
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
Sun, H., Charles, C. H., Lau, L. F., & Tonks, N. K. (1993) · Cell · doi:10.1016/0092-8674(93)90383-2 · Cited by 1,156
Mitogen-activated protein kinases in synaptic plasticity and memory
Sweatt, J. D. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.04.001 · Cited by 995
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
CD45: A Critical Regulator of Signaling Thresholds in Immune Cells
Hermiston, M. L., Xu, Z., & Weiss, A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140946 · Cited by 946
Trowbridge, I. S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.85 · Cited by 755
The Leukocyte Common Antigen Family
Thomas, M. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002011 · Cited by 730
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
Vang, T., Congia, M., Macis, M. D., Musumeci, L., Orrú, V., Zavattari, P., Nika, K., Tautz, L., Taskén, K., Cucca, F., et al. (2005) · Nature Genetics · doi:10.1038/ng1673 · Cited by 728
Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains
Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H., Jansen, P. G., Andersen, H. S., Tonks, N. K., & Møller, N. P. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7117-7136.2001 · Cited by 715
CDC25 phosphatases in cancer cells: key players? Good targets?
Boutros, R., Lobjois, V., & Ducommun, B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2169 · Cited by 714
FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
Sato, T., Irie, S., Kitada, S., & Reed, J. C. (1995) · Science · doi:10.1126/science.7536343 · Cited by 683
Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition
Savagner, P. (2001) · BioEssays · doi:10.1002/bies.1132 · Cited by 679
Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE
Kyogoku, C., Ortmann, W. A., Lee, A., Selby, S., Carlton, V. E. H., Chang, M., Ramos, P., Baechler, E. C., Batliwalla, F. M., Novitzke, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423790 · Cited by 672
Li, X., Ohgi, K. A., Zhang, J., Krones, A., Bush, K. T., Glass, C. K., Nigam, S. K., Aggarwal, A. K., Maas, R., Rose, D. W., et al. (2003) · Nature · doi:10.1038/nature02083 · Cited by 637
Purification of the major protein-tyrosine-phosphatases of human placenta.
Tonks, N. K., Diltz, C. D., & Fischer, E. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68702-2 · Cited by 570
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G., Griffiths, E., Krawczyk, C., Richardson, C. D., Aitken, K., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 562
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
Zhang, S., & Zhang, Z.-Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.011 · Cited by 558
Self-citationMutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers
Wang, Z., Shen, D., Parsons, D. W., Bardelli, A., Sager, J., Szabo, S., Ptak, J., Silliman, N., Peters, B. A., van der Heijden, M. S., et al. (2004) · Science · doi:10.1126/science.1096096 · Cited by 522
Target-based drug discovery: is something wrong?
Sams-Dodd, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03316-1 · Cited by 522
Allosteric inhibition of protein tyrosine phosphatase 1B
Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., Fahr, B. J., Zhong, M., Taylor, L., Randal, M., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb803 · Cited by 519
Galaktionov, K., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90294-9 · Cited by 505
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Smyth, D., Cooper, J. D., Collins, J. E., Heward, J. M., Franklyn, J. A., Howson, J. M. M., Vella, A., Nutland, S., Rance, H. E., Maier, L., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3020 · Cited by 503
Combinatorial control of the specificity of protein tyrosine phosphatases
Tonks, N. K., & Neel, B. G. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00196-4 · Cited by 501
Inside the human cancer tyrosine phosphatome
Julien, S. G., Dubé, N., Hardy, S., & Tremblay, M. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2980 · Cited by 495
Hoffmann, I., Draetta, G., & Karsenti, E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06750.x · Cited by 494
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Keyse, S. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9123-1 · Cited by 490
A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
Li, W., Nishimura, R., Kashishian, A., Batzer, A. G., Kim, W. J., Cooper, J. A., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.509 · Cited by 481
Velaga, M. R., Wilson, V., Jennings, C. E., Owen, C. J., Herington, S., Donaldson, P. T., Ball, S. G., James, R. A., Quinton, R., Perros, P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1108 · Cited by 467
Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba, K., Mishina, M., Manabe, T., & Yamamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008085200 · Cited by 466
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Cdc25A is a novel phosphatase functioning early in the cell cycle.
Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., & Okayama, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06417.x · Cited by 452
Franklin, C. C., & Kraft, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16917 · Cited by 435
Tonks, N. K. (2013) · The FEBS Journal · doi:10.1111/febs.12077 · Cited by 432
Cloutier, J.-F., & Veillette, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.111 · Cited by 421
Araki, T., Mohi, M. G., Ismat, F. A., Bronson, R. T., Williams, I. R., Kutok, J. L., Yang, W., Pao, L. I., Gilliland, D. G., Epstein, J. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1084 · Cited by 420
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
Goldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4283 · Cited by 419
Zinker, B. A., Rondinone, C. M., Trevillyan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298199 · Cited by 414
A negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412
Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression
Peter, M. E. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7907 · Cited by 404
The tyrosine phosphatase Shp2 (PTPN11) in cancer
Chan, G., Kalaitzidis, D., & Neel, B. G. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9126-y · Cited by 382
Cohen, S., Dadi, H., Shaoul, E., Sharfe, N., & Roifman, C. M. (1999) · Blood · doi:10.1182/blood.v93.6.2013.406k25_2013_2024 · Cited by 379
PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells
Hasegawa, K., Martin, F., Huang, G., Tumas, D., Diehl, L., & Chan, A. C. (2004) · Science · doi:10.1126/science.1092138 · Cited by 378
Kinase Drug Discovery – What’s Next in the Field?
Cohen, P., & Alessi, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb300610s · Cited by 377
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Chan, R. J., & Feng, G.-S. (2007) · Blood · doi:10.1182/blood-2006-07-028829 · Cited by 371
Freeman, R. M., Plutzky, J., & Neel, B. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11239 · Cited by 360
Protein tyrosine phosphatases and the immune response
Mustelin, T., Vang, T., & Bottini, N. (2005) · Nature Reviews Immunology · doi:10.1038/nri1530 · Cited by 354
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.
Sadhu, K., Reed, S. I., Richardson, H., & Russell, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5139 · Cited by 350
Theodosiou, A., & Ashworth, A. (2002) · Genome biology · doi:10.1186/gb-2002-3-7-reviews3009 · Cited by 335
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Barf, T., & Kaptein, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003203 · Cited by 331
The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers
Monks, T., & Jones, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337388 · Cited by 326
Combs, A. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901090b · Cited by 317
Bjorge, J. D., Pang, A., & Fujita, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004852200 · Cited by 316
Julien, S. G., Dubé, N., Read, M., Penney, J., Paquet, M., Han, Y., Kennedy, B. P., Muller, W. J., & Tremblay, M. L. (2007) · Nature Genetics · doi:10.1038/ng1963 · Cited by 316
Kristjánsdóttir, K., & Rudolph, J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.07.007 · Cited by 313
Matthews, D. C., Appelbaum, F. R., Eary, J. F., Fisher, D. R., Durack, L. D., Hui, T. E., Martin, P. J., Mitchell, D., Press, O. W., Storb, R., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1237 · Cited by 312
Blomberg, I., & Hoffmann, I. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6183 · Cited by 291
Zhang, S. Q., Tsiaras, W. G., Araki, T., Wen, G., Minichiello, L., Klein, R., & Neel, B. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4062-4072.2002 · Cited by 282
PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
Zeng, Q., Dong, J., Guo, K., Li, J., Tan, H.-X., Koh, V., Pallen, C. J., Manser, E. J., & Hong, W. (2003) · PubMed · Cited by 277
Cdc25: mechanisms of checkpoint inhibition and recovery
Karlsson-Rosenthal, C., & Millar, J. B. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.002 · Cited by 276
PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity
Zhang, Z.-Y., & Lee, S.-Y. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.223 · Cited by 271
Self-citationRegulation of MAP kinases by MAP kinase phosphatases
Kondoh, K., & Nishida, E. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.002 · Cited by 268
Lessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
Aceto, N., Sausgruber, N., Brinkhaus, H., Gaidatzis, D., Martiny-Baron, G., Mazzarol, G., Confalonieri, S., Quarto, M., Hu, G., Balwierz, P. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2645 · Cited by 261
Bandyopadhyay, D., Kusari, A., Kenner, K. A., Liu, F., Chernoff, J., Gustafson, T. A., & Kusari, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1639 · Cited by 257
Zhang, J., Zahir, N., Jiang, Q., Miliotis, H., Heyraud, S., Meng, X., Dong, B., Xie, G., Qiu, F., Hao, Z., et al. (2011) · Nature Genetics · doi:10.1038/ng.904 · Cited by 252
Majeti, R., Xu, Z., Parslow, T. G., Olson, J. L., Daikh, D. I., Killeen, N., & Weiss, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00209-9 · Cited by 250
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Zantek, N. D., Azimi, M., Fedor‐Chaiken, M., Wang, B., Brackenbury, R. W., & Kinch, M. S. (1999) · PubMed · Cited by 249
Cloutier, J. F., & Veillette, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00871.x · Cited by 240
Gabrielli, B. G., Souza, C. P. C. D., Tonks, I. D., Clark, J. M., Hayward, N. K., & Ellem, K. A. O. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.1081 · Cited by 236
Charles, C. H., Abler, A. S., & Lau, L. F. (1992) · PubMed · Cited by 233
Ahmad, F., Li, P.-M., Meyerovitch, J., & Goldstein, B. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20503 · Cited by 229
Kurup, P., Zhang, Y., Xu, J., Venkitaramani, D. V., Haroutunian, V., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0157-10.2010 · Cited by 224
Sieh, M., Bolen, J. B., & Weiss, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05659.x · Cited by 218
Protein-Tyrosine Phosphatase 1B Is Required for HER2/Neu–Induced Breast Cancer
Bentires-Alj, M., & Neel, B. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4610 · Cited by 216
Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Identification of a gene expression signature associated with pediatric AML prognosis
Yagi, T. (2003) · Blood · doi:10.1182/blood-2003-02-0578 · Cited by 209
Zeng, Q., Si, X., Horstmann, H., Xu, Y., Hong, W., & Pallen, C. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000453200 · Cited by 208
Dorfman, K. S., Carrasco, D., Gruda, M. C., Ryan, C., Lira, S. A., & Bravo, R. (1996) · PubMed · Cited by 207
Mattoon, D. R., Lamothe, B., Lax, I., & Schlessinger, J. (2004) · BMC Biology · doi:10.1186/1741-7007-2-24 · Cited by 207
Lee, A. T., Li, W., Liew, A., Bombardier, C., Weisman, M., Massarotti, E. M., Kent, J., Wolfe, F., Begovich, A. B., & Gregersen, P. K. (2005) · Genes & Immunity · doi:10.1038/sj.gene.6364159 · Cited by 203
PRL PTPs: mediators and markers of cancer progression
Bessette, D. C., Qiu, D., & Pallen, C. J. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9121-3 · Cited by 202
Lindqvist, A., Källström, H., Lundgren, A., Barsoum, E., & Rosenthal, C. K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503066 · Cited by 200
Nagata, A., Igarashi, M., Jinno, S., et al. (1991) · PubMed · Cited by 199
Zhang, X., He, Y., Liu, S., Yu, Z., Jiang, Z.-X., Yang, Z., Dong, Y., Nabinger, S. C., Wu, L., Gunawan, A. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901645u · Cited by 199
Self-citationCahir McFarland, E. D., Hurley, T. R., Pingel, J. T., Sefton, B. M., Shaw, A., & Thomas, M. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1402 · Cited by 198
The two faces of PTP1B in cancer
Lessard, L., Stuible, M., & Tremblay, M. L. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.018 · Cited by 197
A point mutation in PTPRC is associated with the development of multiple sclerosis
Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R., Wonigeit, K., Lindert, R.-B., Kantarci, O., Schaefer-Klein, J., et al. (2000) · Nature Genetics · doi:10.1038/82659 · Cited by 195
Zhang, Y., Venkitaramani, D. V., Gladding, C. M., Zhang, Y., Kurup, P., Molnar, E., Collingridge, G. L., & Lombroso, P. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2666-08.2008 · Cited by 191
McNeill, L., Salmond, R. J., Cooper, J. C., Carret, C. K., Cassady-Cain, R. L., Roche-Molina, M., Tandon, P., Holmes, N., & Alexander, D. R. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.015 · Cited by 189
Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line
Kaszubska, W., Falls, H. D., Schaefer, V. G., Haasch, D., Frost, L., Hessler, P., Kroeger, P. E., White, D. W., Jirousek, M. R., & Trevillyan, J. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00178-8 · Cited by 189
Human homologue of murine T200 glycoprotein.
Omary, M. B., Trowbridge, I. S., & Battifora, H. A. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.4.842 · Cited by 189
Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum.
Lombroso, P. J., Murdoch, G., & Lerner, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7242 · Cited by 188
Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420
Nguyen, T.-H., Liu, J., & Lombroso, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111683200 · Cited by 185
Gjörloff-Wingren, A., Saxena, M., Williams, S., Hammi, D., & Mustelin, T. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199912)29:12<3845::aid-immu3845>3.0.co;2-u · Cited by 185
Positive and negative regulation of Src-family membrane kinases by CD45
Thomas, M. L., & Brown, E. J. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01506-6 · Cited by 178
A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models
Dai, X., James, R. G., Habib, T., Singh, S., Jackson, S., Khim, S., Moon, R. T., Liggitt, D., Wolf-Yadlin, A., Buckner, J. H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66963 · Cited by 178
Protein Tyrosine Phosphatases in Autoimmunity
Vang, T., Miletic, A. V., Arimura, Y., Tautz, L., Rickert, R. C., & Mustelin, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090418 · Cited by 178
Guan, K.-L., & Butch, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7197 · Cited by 177
Hanafusa, H., Torii, S., Yasunaga, T., Matsumoto, K., & Nishida, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312498200 · Cited by 174
Wiener, J. R., Kerns, B.-J. M., Harvey, E. L., Conaway, M. R., lglehart, J. D., Berchuck, A., & Bast, R. C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.372 · Cited by 172
Loda, M. F., Capodieci, P., Mishra, R., Yao, H. W., Corless, C. L., Grigioni, W. F., Wang, Y., Magi-Galluzzi, C., & Stork, P. A. (1996) · Europe PMC (PubMed Central) · Cited by 171
Ren, Y., Meng, S., Mei, L., Zhao, Z. J., Jove, R., & Wu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312575200 · Cited by 171
Roach, T., Slater, S., Koval, M., White, L., McFarland, E. C., Okumura, M., Thomas, M., & Brown, E. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00188-6 · Cited by 169
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
Schickel, R., Park, S.-M., Murmann, A. E., & Peter, M. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.018 · Cited by 167
Selecting protein tyrosine phosphatases as drug targets
van Huijsduijnen, R. H., Bombrun, A., & Swinnen, D. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02438-8 · Cited by 166
The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching
Jeanneteau, F., Deinhardt, K., Miyoshi, G., Bennett, A. M., & Chao, M. V. (2010) · Nature Neuroscience · doi:10.1038/nn.2655 · Cited by 163
PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation
Liang, F., Liang, J., Wang, W.-Q., Sun, J.-P., Udho, E., & Zhang, Z.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608940200 · Cited by 162
Self-citationRondinone, C. M., Trevillyan, J. M., Clampit, J., Gum, R. J., Berg, C., Kroeger, P., Frost, L., Zinker, B. A., Reilly, R., Ulrich, R., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2405 · Cited by 159
Goebel-Goody, S. M., Baum, M., Paspalas, C. D., Fernandez, S. M., Carty, N. C., Kurup, P., & Lombroso, P. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003053 · Cited by 159
Identification of a Putative Syp Substrate, the PDGFβ Receptor
Klinghoffer, R. A., & Kazlauskas, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22208 · Cited by 157
Chan, R. J., Leedy, M. B., Munugalavadla, V., Voorhorst, C. S., Li, Y., Yu, M., & Kapur, R. (2005) · Blood · doi:10.1182/blood-2004-10-4002 · Cited by 156
Magi-Galluzzi, C., Mishra, R., Fiorentino, M., Montironi, R., Yao, H. W., Capodieci, P., Wishnow, K., Kaplan, I. D., Stork, P. A., & Loda, M. F. (1997) · PubMed · Cited by 155
Centrosomal and Cytoplasmic Cdc2/Cyclin B1 Activation Precedes Nuclear Mitotic Events
Souza, C. P. C. D., Ellem, K. A. O., & Gabrielli, B. G. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4872 · Cited by 154
The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function
Alexander, D. R. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0218 · Cited by 152
PRL phosphatases as potential molecular targets in cancer
Stephens, B. J., Han, H., Gokhale, V. M., & Hoff, D. D. V. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0248 · Cited by 149
Kikawa, K. D., Vidale, D. R., Etten, R. L. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207127200 · Cited by 148
A novel, specific interaction involving the Csk SH3 domain and its natural ligand.
Ghose, R., Shekhtman, A. G., Goger, M. J., Ji, H., & Cowburn, D. (2001) · Nature Structural Biology · doi:10.1038/nsb1101-998 · Cited by 146
The role of protein tyrosine phosphatase 1B in Ras signaling
Dubé, N., Cheng, A., & Tremblay, M. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304242101 · Cited by 141
Sonneveld, E., Brink, C. E. V. D., van der Leede, B. M., Schulkes, R.-K. A. M., Petkovich, M. P., van der Burg, B., & van der Saag, P. T. (1998) · PubMed · Cited by 141
Dual-specificity phosphatases as targets for antineoplastic agents
Lyon, M. A., Ducruet, A. P., Wipf, P., & Lazo, J. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd963 · Cited by 139
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
Lund, I. K., Hansen, J. A., Andersen, H. S., Møller, N. P. H., & Billestrup, N. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01694 · Cited by 139
LYP inhibits T-cell activation when dissociated from CSK
Vang, T., Liu, W. H., Delacroix, L., Wu, S., Vasile, S., Dahl, R. S., Yang, L., Musumeci, L., Francis, D. M., Landskron, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.916 · Cited by 138
The Molecular Interaction of Fas and FAP-1
Yanagisawa, J., Takahashi, M., Kanki, H., Yano-Yanagisawa, H., Tazunoki, T., Sawa, E., Nishitoba, T., Kamishohara, M., Kobayashi, E., Kataoka, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8539 · Cited by 138
Small molecule tools for functional interrogation of protein tyrosine phosphatases
He, R., Zeng, L., He, Y., Zhang, S., & Zhang, Z. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08718.x · Cited by 137
Self-citationCutting Edge: The CD45 Tyrosine Phosphatase Is an Inhibitor of Lck Activity in Thymocytes
D’Oro, U., & Ashwell, J. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.1879 · Cited by 137
Altered CD45 expression and disease
Tchilian, E. Z., & Beverley, P. C. L. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.01.001 · Cited by 135
Haj, F. G., Zabolotny, J. M., Kim, Y., Kahn, B. B., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413240200 · Cited by 132
Vicent, S., Garayoa, M., López-Picazo, J. M., Lozano, M. D., Toledo, G., Thunnissen, E., Manzano, R. G., & Montuenga, L. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0771 · Cited by 132
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Chan, G., Kalaitzidis, D., Usenko, T. S., Kutok, J. L., Yang, W., Mohi, G., & Neel, B. G. (2009) · Blood · doi:10.1182/blood-2008-10-182626 · Cited by 126
The C-terminus of p53: the more you learn the less you know.
Ahn, J., & Prives, C. L. (2001) · Nature Structural Biology · doi:10.1038/nsb0901-730 · Cited by 123
Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis
Vandiedonck, C., Capdevielle, C., Giraud, M., Krumeich, S., Jaïs, J., Eymard, B., Tranchant, C., Gajdos, P., & Garchon, H. (2006) · Annals of Neurology · doi:10.1002/ana.20751 · Cited by 123
Mauri, C., Mars, L. T., & Londei, M. (2000) · Nature Medicine · doi:10.1038/76251 · Cited by 120
Lombroso, P., Naegele, J. R., Sharma, E., & Lerner, M. R. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-07-03064.1993 · Cited by 119
Molecular mechanisms of the PRL phosphatases
Ríos, P., Li, X., & Köhn, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08565.x · Cited by 116
A CD45 Polymorphism Associated with Multiple Sclerosis Disrupts an Exonic Splicing Silencer
Lynch, K. W., & Weiss, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102175200 · Cited by 116
Mitogen-Activated Protein Kinase Phosphatase-1 Is a Mediator of Breast Cancer Chemoresistance
Small, G. W., Shi, Y., Higgins, L. S., & Orlowski, R. Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2644 · Cited by 113
Luo, Y., Liang, F., & Zhang, Z. (2009) · Biochemistry · doi:10.1021/bi8020789 · Cited by 111
Self-citationFAP-1 Association with Fas (Apo-1) Inhibits Fas Expression on the Cell Surface
Ivanov, V. N., Lopez‐Bergami, P., Maulit, G., Sato, T., Sassoon, D. A., & Ronai, Z. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3623-3635.2003 · Cited by 111
Caboche, J., Valjent, E., & Vanhoutte, P. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:083 · Cited by 111
Denkert, C., Schmitt, W., Berger, S. M., Reles, A., Pest, S., Siegert, A., Lichtenegger, W., Dietel, M., & Hauptmann, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10746 · Cited by 110
Desai, D. M., Sap, J., Silvennoinen, O., Schlessinger, J., & Weiss, A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06716.x · Cited by 109
Yanagi, S., Sugawara, H., Kurosaki, M., Sabe, H., Yamamura, H., & Kurosaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30487 · Cited by 108
Maekawa, K., Imagawa, N., Nagamatsu, M., & Harada, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80273-4 · Cited by 107
PDGF receptor as a specific in vivo target for low Mr phosphotyrosine protein phosphatase
Chiarugi, P., Cirri, P., Raugei, G., Camici, G., Dolfi, F., Berti, A., & Ramponi, G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00947-8 · Cited by 105
Miyamoto, D., Miyamoto, M., Takahashi, A., Yomogita, Y., Higashi, H., Kondo, S., & Hatakeyama, M. (2008) · Oncogene · doi:10.1038/sj.onc.1211019 · Cited by 105
LMW-PTP Is a Negative Regulator of Insulin-Mediated Mitotic and Metabolic Signalling
Chiarugi, P., Cirri, P., Marra, F., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7355 · Cited by 104
Saras, J., Claesson, L., Heldin, C., & Góñez, L. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51050-x · Cited by 102
Stone, J. D., Conroy, L. A., Byth, K. F., Hederer, R. A., Howlett, S., Takemoto, Y., Holmes, N. J., & Alexander, D. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5773 · Cited by 99
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
Chattopadhyay, S., Machado-Pinilla, R., Manguán-García, C., Belda-Iniesta, C., Moratilla, C., Cejas, P., Vara, J. Á. F., de Castro-Carpeño, J., Casado, E., Nistal, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209364 · Cited by 96
Peng, L., Xing, X., Li, W., Qu, L., Meng, L., Lian, S., Jiang, B., Wu, J. L., & Shou, C. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-110 · Cited by 95
Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis
Sulisalo, T., Sistonen, P., Hästbacka, J., Wadelius, C., Mäkitie, O., de la Chapelle, A., & Kaitila, I. (1993) · Nature Genetics · doi:10.1038/ng0493-338 · Cited by 94
Small, G. W., Shi, Y., Edmund, N. A., Somasundaram, S., Moore, D. T., & Orlowski, R. Z. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003400 · Cited by 93
CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases.
Burns, C. M., Sakaguchi, K., Appella, E., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36871-0 · Cited by 92
Banville, D. L., Ahmad, S., Stocco, R., & Shen, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31792-1 · Cited by 90
Sun, J., Wang, W., Yang, H., Liu, S., Liang, F., Fedorov, A. A., Almo, S. C., & Zhang, Z. (2005) · Biochemistry · doi:10.1021/bi0509191 · Cited by 90
Self-citationYing, J., Li, H., Cui, Y., Wong, A., Langford, C., & Tao, Q. (2006) · Leukemia · doi:10.1038/sj.leu.2404193 · Cited by 90
Venkitaramani, D. V., Paul, S., Zhang, Y., Kurup, P. K., Ding, L., Tressler, L., Allen, M. R., Sacca, R. E., Picciotto, M. R., & Lombroso, P. J. (2008) · Synapse · doi:10.1002/syn.20608 · Cited by 89
Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells
Al-Aidaroos, A. Q., Yuen, H. F., Guo, K., Zhang, S., Chung, T., Chng, W. J., & Zeng, Q. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66824 · Cited by 89
Ewing's Sarcoma Oncoprotein EWS–FLI1: The Perfect Target Without a Therapeutic Agent
Üren, A., & Toretsky, J. A. (2005) · Future Oncology · doi:10.2217/14796694.1.4.521 · Cited by 87
Achiwa, H., & Lazo, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2436 · Cited by 85
Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions
Lawan, A., Shi, H., Gatzke, F., & Bennett, A. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1041-2 · Cited by 85
Chiarugi, P., Cirri, P., Marra, F., Raugei, G., Fiaschi, T., Camici, G., Manao, G., Romanelli, R. G., & Ramponi, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6776 · Cited by 85
Irie, S., Hachiya, T., Rabizadeh, S., Maruyama, W., Mukai, J., Li, Y., Reed, J. C., Bredesen, D. E., & Sato, T.-A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01324-1 · Cited by 85
CD45 and Src-family kinases: and now for something completely different
Ashwell, J. D., & D’Oro, U. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01505-4 · Cited by 84
Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B
Ma, Z.-Q., Chua, S. S., DeMayo, F. J., & Tsai, S. Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202809 · Cited by 83
FAP-1 in pancreatic cancer cells
Ungefroren, H., Kruse, M., Trauzold, A., Roeschmann, S., Röder, C., Arlt, A., Henne‐Bruns, D., & Kalthoff, H. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.15.2735 · Cited by 81
Carty, N., Xu, J., Kurup, P., Brouillette, J., Goody, S. M. G., Austin, D. R., Yuan, P., Chen, G., Correa, P. R., Haroutunian, V., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.63 · Cited by 81
Hardy, S., Wong, N. N., Muller, W. J., Park, M., & Tremblay, M. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2041 · Cited by 79
Vogel, A., Strassburg, C. P., & Manns, M. P. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6363918 · Cited by 78
Pandey, S., Yu, X. X., Watts, L. M., Michael, M. D., Sloop, K. W., Rivard, A. L., Leedom, T. A., Manchem, V. P., Samadzadeh, L., McKay, R. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609626200 · Cited by 78
Erdmann, K. S., Kuhlmann, J., Leßmann, V., Herrmann, L., Eulenburg, V., Müller, O., & Heumann, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203725 · Cited by 78
Kessel, M., Wildhaber, I., Cohen, S., & Baumeister, W. P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02974.x · Cited by 77
Expression of the p56lck Y505F Mutation in CD45-Deficient Mice Rescues Thymocyte Development
Seavitt, J. R., White, L. S., MURPHY, K. M. M., Loh, D. Y., Perlmutter, R. M., & Thomas, M. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4200 · Cited by 77
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling
Zhu, J.-H., Chen, R., Yi, W., Cantin, G. T., Fearns, C., Yang, Y. C., Yates, J. R., & Lee, J. ‐. (2007) · Oncogene · doi:10.1038/sj.onc.1210922 · Cited by 76
EphrinA1 Repulsive Response Is Regulated by an EphA2 Tyrosine Phosphatase
Parri, M., Buricchi, F., Taddei, M. L., Giannoni, E., Raugei, G., Ramponi, G., & Chiarugi, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502879200 · Cited by 76
Liu, W., Yu, B., Xu, G., Xu, W.-R., Loh, M. L., Li-da, T., & Qu, C. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400474r · Cited by 76
Baer, C., Nees, M., Breit, S., Selle, B., Kulozik, A. E., Schaefer, K., Braun, Y., Wai, D., & Poremba, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20171 · Cited by 76
Nakahira, M., Tanaka, T., Robson, B. E., Mizgerd, J. P., & Grusby, M. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.010 · Cited by 76
Hicklin, T. R., Wu, P. H., Radcliffe, R. A., Freund, R. K., Goebel-Goody, S. M., Correa, P. R., Proctor, W. R., Lombroso, P. J., & Browning, M. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017856108 · Cited by 76
PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis
Abaan, O. D., Levenson, A. E., Khan, O. A., Furth, P. A., Üren, A., & Toretsky, J. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208247 · Cited by 75
Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy
Emanuel, P. D., Shannon, K., & Castleberry, R. P. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)10044-7 · Cited by 75
Quantum yield in the oxidation of firefly luciferin
Seliger, H. H., & McElroy, W. D. (1959) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(59)90082-8 · Cited by 74
Orozco, J. J., Bäck, T. A., Kenoyer, A. L., Balkin, E. R., Hamlin, D. K., Wilbur, D. S., Fisher, D. R., Frayo, S. L., Hylarides, M. D., Green, D. J., et al. (2013) · Blood · doi:10.1182/blood-2012-11-467035 · Cited by 74
Cited by
Targeted protein degradation by PROTACs
Neklesa, T. K., Winkler, J. D., & Crews, C. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.027 · Cited by 599
The cellular and molecular bases of leptin and ghrelin resistance in obesity
Cui, H., López, M., & Rahmouni, K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.222 · Cited by 477
CD45 in human physiology and clinical medicine
Rheinländer, A., Schraven, B., & Bommhardt, U. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.009 · Cited by 294
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation
Zhu, G., Xie, J., Kong, W., Xie, J., Li, Y., Du, L., Zheng, Q., Sun, L., Guan, M., Li, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.002 · Cited by 267
Self-citationAntidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Nowell, J., Blunt, E., Gupta, D., & Edison, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101979 · Cited by 179
Metadata
- Authors
- He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y.
- Venue
- Acta Pharmacologica Sinica
- Published
- 2014-09-15
- Volume
- 35
- Issue
- 10
- Pages
- 1227-1246
- ISSN
- 0253-9756 (ISSN-L)
- 1671-4083
- 1745-7254
- OpenAlex
- W2015964672
- Cited by
- 327
- References
- 253
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
